As of Apr 2025 ยท from Reg CF Offering (2024) ยท pre-money + amount raised, not a traded price
Total raised
$4,154,032
Across 2 rounds since 2022
Latest share price
$13.30
Reg CF Offering (2024) offering price
Financials
FY2020โFY2025 ยท from SEC filings ยท hover any figure for its source
$3.3M
โ$132K
2020
$3.4M
โ$88K
2021
$2.7M
โ$958K
2022
$2.5M
โ$972K
2023
$2.3M
โ$1.8M
2024
$2.3M
โ$1.9M
2025
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$3,307,604
$3,432,626
$2,652,961
$2,461,652
$2,333,312
$2,343,860
Cost of goods sold
$2,057,892
$2,018,550
$1,633,334
$1,611,565
$1,247,568
$1,274,069
Gross margin
38%
41%
38%
35%
47%
46%
Net income
-$132,280
-$87,788
-$957,994
-$971,790
-$1,828,658
-$1,940,056
Taxes paid
$10,763
$0
$0
$0
$8,579
$5,865
Balance sheet
Cash
$121,268
$63,721
$157,402
$779,979
$716,076
$737,830
Accounts receivable
$75,638
$70,540
$54,845
$45,140
$0
$116,274
Total assets
$338,438
$347,134
$419,897
$1,043,681
$1,132,151
$1,251,586
Short-term debt
$324,523
$160,024
$469,381
$82,191
$304,573
$369,082
Long-term debt
$0
$269,123
$541,683
$30,000
$0
$0
Total liabilities
$324,523
$429,147
$1,011,064
$112,191
$304,573
$369,082
Other
Headcount
โ
7
3
5
3
3
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.